PROCEDURE FOR STRUCTURAL CHARACTERIZATION OF A RECOMBINANT POLYCLONAL PROTEIN OR A POLYCLONAL CELL LINE

Patent №

US 8,288,109

Granted

2012-10-16

Filed 2007

Owner

SYMPHOGEN A/S

Lab

AI components

1

hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

11658021

The present invention provides a structural characterization platform that can be used to assess the stability of a polyclonal cell line during production, as well as batch-to-batch consistency of the final polyclonal products. The structural characterization platform is based on genetic analyses as well as protein characterization techniques that alone or in combination provide the necessary information to characterize the polyclonal cell line and final products. The collection of different homologous proteins to be analyzed with the platform techniques if for example a recombinant polyclonal antibody or a mixture of monoclonal antibodies.

AI hardwareC12Q 1/6876G01N 30/96G01N 33/6803

AI classification

AI hardware0.58
Evolutionary computation0.12
Natural language0.02
Knowledge representation0.01
Machine learning0.00
Vision0.00
Planning0.00
Speech0.00

Ownership

SYMPHOGEN A/S

assignment · 191770949

Assignors

RASMUSSEN, LONE KJAER, FRANDSEN, TORBEN, RASMUSSEN, SOREN KOFOED, ANDERSEN, PETER SEJER

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC